Contextlogic Inc Financials

LOGC Stock  USD 7.57  0.01  0.13%   
Based on the measurements of operating efficiency obtained from Contextlogic Inc's historical financial statements, Contextlogic is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.
With this module, you can analyze Contextlogic Inc financials for your investing period. You should be able to track the changes in Contextlogic Inc individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
The data published in Contextlogic Inc's official financial statements typically reflect Contextlogic Inc's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Contextlogic Inc's quantitative information. For example, before you start analyzing numbers published by Contextlogic Inc accountants, it's essential to understand Contextlogic Inc's liquidity, profitability, and earnings quality within the context of the Broadline Retail space in which it operates.
Please note, the presentation of Contextlogic Inc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Contextlogic Inc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Contextlogic Inc's management manipulating its earnings.

Contextlogic Inc Stock Summary

Contextlogic Inc competes with Baozun, 1 800, ChargePoint Holdings, Studio City, and Designer Brands. LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Logicbio Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 62 people.
InstrumentUSA OTC Stock View All
ExchangeOTCQB Exchange
ISINUS21078F1093
Business Address2648 International Blvd,
SectorBroadline Retail
IndustryConsumer Discretionary
BenchmarkDow Jones Industrial
Websiteir.contextlogicinc.com
Phone415 965 8476
CurrencyUSD - US Dollar

Contextlogic Inc Key Financial Ratios

Contextlogic Inc's financial ratios allow both analysts and investors to convert raw data from Contextlogic Inc's financial statements into concise, actionable information that can be used to evaluate the performance of Contextlogic Inc over time and compare it to other companies across industries.

Contextlogic Inc Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Contextlogic Inc's current stock value. Our valuation model uses many indicators to compare Contextlogic Inc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Contextlogic Inc competition to find correlations between indicators driving Contextlogic Inc's intrinsic value. More Info.
Contextlogic is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Contextlogic Inc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Contextlogic Inc's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Contextlogic Inc Systematic Risk

Contextlogic Inc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Contextlogic Inc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Contextlogic Inc correlated with the market. If Beta is less than 0 Contextlogic Inc generally moves in the opposite direction as compared to the market. If Contextlogic Inc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Contextlogic Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Contextlogic Inc is generally in the same direction as the market. If Beta > 1 Contextlogic Inc moves generally in the same direction as, but more than the movement of the benchmark.

Contextlogic Inc January 5, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Contextlogic Inc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Contextlogic. We use our internally-developed statistical techniques to arrive at the intrinsic value of Contextlogic based on widely used predictive technical indicators. In general, we focus on analyzing Contextlogic Inc OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Contextlogic Inc's daily price indicators and compare them against related drivers.

Complementary Tools for Contextlogic Inc OTC Stock analysis

When running Contextlogic Inc's price analysis, check to measure Contextlogic Inc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Contextlogic Inc is operating at the current time. Most of Contextlogic Inc's value examination focuses on studying past and present price action to predict the probability of Contextlogic Inc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Contextlogic Inc's price. Additionally, you may evaluate how the addition of Contextlogic Inc to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device